222 related articles for article (PubMed ID: 25188299)
21. Prognostic implications of PD-L1 expression in patients with soft tissue sarcoma.
Kim C; Kim EK; Jung H; Chon HJ; Han JW; Shin KH; Hu H; Kim KS; Choi YD; Kim S; Lee YH; Suh JS; Ahn JB; Chung HC; Noh SH; Rha SY; Kim SH; Kim HS
BMC Cancer; 2016 Jul; 16():434. PubMed ID: 27393385
[TBL] [Abstract][Full Text] [Related]
22. Lessons from genetic profiling in soft tissue sarcomas.
Nilbert M; Meza-Zepeda LA; Francis P; Berner JM; Namløs HM; Fernebro J; Myklebost O
Acta Orthop Scand Suppl; 2004 Apr; 75(311):35-50. PubMed ID: 15188664
[TBL] [Abstract][Full Text] [Related]
23. Establishing biomarkers for soft tissue sarcomas.
Czarnecka AM; Chmiel P; Błoński P; Rutkowski P
Expert Rev Anticancer Ther; 2024 Jun; 24(6):407-421. PubMed ID: 38682679
[TBL] [Abstract][Full Text] [Related]
24. Reduced expression of hMSH2 protein is correlated to poor survival for soft tissue sarcoma patients.
Taubert HW; Bartel F; Kappler M; Schuster K; Meye A; Lautenschläger C; Thamm-Mücke B; Bache M; Schmidt H; Holzhausen HJ; Würl P
Cancer; 2003 May; 97(9):2273-8. PubMed ID: 12712483
[TBL] [Abstract][Full Text] [Related]
25. Molecular Pathogenesis and Diagnostic, Prognostic and Predictive Molecular Markers in Sarcoma.
Mariño-Enríquez A; Bovée JV
Surg Pathol Clin; 2016 Sep; 9(3):457-73. PubMed ID: 27523972
[TBL] [Abstract][Full Text] [Related]
26. Molecular profiling in the diagnosis and treatment of high grade sarcomas.
Antonescu CR
Ultrastruct Pathol; 2008; 32(2):37-42. PubMed ID: 18446666
[TBL] [Abstract][Full Text] [Related]
27. Prognostic value of myogenic differentiation in undifferentiated pleomorphic sarcomas of soft tissue.
Cipriani NA; Kurzawa P; Ahmad RA; Deshpande V; Hornicek FJ; Mullen JT; Nielsen GP
Hum Pathol; 2014 Jul; 45(7):1504-8. PubMed ID: 24780826
[TBL] [Abstract][Full Text] [Related]
28. Alterations of INK4A and INK4B genes in adult soft tissue sarcomas: effect on survival.
Orlow I; Drobnjak M; Zhang ZF; Lewis J; Woodruff JM; Brennan MF; Cordon-Cardo C
J Natl Cancer Inst; 1999 Jan; 91(1):73-9. PubMed ID: 9890173
[TBL] [Abstract][Full Text] [Related]
29. An evidence-based guideline on the application of molecular testing in the diagnosis, prediction of prognosis, and selection of therapy in non-GIST soft tissue sarcomas.
Yao X; Ghert M; Dickson BC; Popovic S; Purgina BM; Verma S; Werier J; Kandel RA
Cancer Treat Rev; 2020 Apr; 85():101987. PubMed ID: 32092619
[TBL] [Abstract][Full Text] [Related]
30. The retinoblastoma family member pRb2/p130 is an independent predictor of survival in human soft tissue sarcomas.
Masciullo V; Berardengo E; Boglione A; Sgambato A; Bernardi A; Forni M; Linari A; Cito L; Scambia G; Comandone A; Giordano A
Clin Cancer Res; 2008 Aug; 14(15):4775-9. PubMed ID: 18676747
[TBL] [Abstract][Full Text] [Related]
31. Determining the prognostic significance of alternative splicing events in soft tissue sarcoma using data from The Cancer Genome Atlas.
Yang X; Huang WT; He RQ; Ma J; Lin P; Xie ZC; Ma FC; Chen G
J Transl Med; 2019 Aug; 17(1):283. PubMed ID: 31443718
[TBL] [Abstract][Full Text] [Related]
32. Microsatellite instability and hMLH1 and hMSH2 expression analysis in soft tissue sarcomas.
Kawaguchi K; Oda Y; Takahira T; Saito T; Yamamoto H; Kobayashi C; Tamiya S; Oda S; Iwamoto Y; Tsuneyoshi M
Oncol Rep; 2005 Feb; 13(2):241-6. PubMed ID: 15643505
[TBL] [Abstract][Full Text] [Related]
33. Molecular characterisation of soft tissue tumours: a gene expression study.
Nielsen TO; West RB; Linn SC; Alter O; Knowling MA; O'Connell JX; Zhu S; Fero M; Sherlock G; Pollack JR; Brown PO; Botstein D; van de Rijn M
Lancet; 2002 Apr; 359(9314):1301-7. PubMed ID: 11965276
[TBL] [Abstract][Full Text] [Related]
34. Integration of genomic copy number variations and chemotherapy-response biomarkers in pediatric sarcoma.
Cheng L; Pandya PH; Liu E; Chandra P; Wang L; Murray ME; Carter J; Ferguson M; Saadatzadeh MR; Bijangi-Visheshsaraei K; Marshall M; Li L; Pollok KE; Renbarger JL
BMC Med Genomics; 2019 Jan; 12(Suppl 1):23. PubMed ID: 30704460
[TBL] [Abstract][Full Text] [Related]
35. Experiences from tissue microarray in soft tissue sarcomas.
Nilbert M; Engellau J
Acta Orthop Scand Suppl; 2004 Apr; 75(311):29-34. PubMed ID: 15188663
[TBL] [Abstract][Full Text] [Related]
36. Establishment and molecular characterisation of seven novel soft-tissue sarcoma cell lines.
Salawu A; Fernando M; Hughes D; Reed MW; Woll P; Greaves C; Day C; Alhajimohammed M; Sisley K
Br J Cancer; 2016 Oct; 115(9):1058-1068. PubMed ID: 27560552
[TBL] [Abstract][Full Text] [Related]
37. MicroRNAs in soft tissue sarcomas: overview of the accumulating evidence and importance as novel biomarkers.
Fujiwara T; Kunisada T; Takeda K; Uotani K; Yoshida A; Ochiya T; Ozaki T
Biomed Res Int; 2014; 2014():592868. PubMed ID: 25165708
[TBL] [Abstract][Full Text] [Related]
38. Elevated expression level of survivin protein in soft-tissue sarcomas is a strong independent predictor of survival.
Kappler M; Kotzsch M; Bartel F; Füssel S; Lautenschläger C; Schmidt U; Würl P; Bache M; Schmidt H; Taubert H; Meye A
Clin Cancer Res; 2003 Mar; 9(3):1098-104. PubMed ID: 12631613
[TBL] [Abstract][Full Text] [Related]
39. Gene expression profiling for the investigation of soft tissue sarcoma pathogenesis and the identification of diagnostic, prognostic, and predictive biomarkers.
Beck AH; West RB; van de Rijn M
Virchows Arch; 2010 Feb; 456(2):141-51. PubMed ID: 19412622
[TBL] [Abstract][Full Text] [Related]
40. High bad and bcl-xL gene expression and combined bad, bcl-xL, bax and bcl-2 mRNA levels: molecular predictors for survival of stage 2 soft tissue sarcoma patients.
Köhler T; Würl P; Meye A; Lautenschläger C; Bartel F; Borchert S; Bache M; Schmidt H; Holzhausen HJ; Taubert H
Anticancer Res; 2002; 22(3):1553-9. PubMed ID: 12168836
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
